August 15, 2017 : DCMS #358

SPECIAL FEATURE

Diabetes Doesn’t Stop These Athletes

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Dr. Karl Nadolsky Part 5, Final Thoughts

HOMERUN SLIDES — Great Clinical Presentation Highlights

A Unifying Pathophysiologic Approach to The Complications of Diabetes in the Context of the Beta-cell Classification of Diabetes Part 7

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #86: Measuring Insulin Action In Vivo

MOST POPULAR ARTICLES OF THE MONTH

#1 Type 1 Cured in Mice
#2 Coffee Consumption and Mortality: The Final Word
#3 Novel Antihypertensive Lowers HbA1c in People with Diabetes

We have been following Team NovoNordisk for the past few weeks as they have been in 3 major races. As you can imagine, having consistent accurate readings for the team doctor as they are riding could make a difference. But how would that be possible?  Would it make a big difference? Would the team do better? Well, sometimes we don’t get the whole scoop but I can share something that Phil Sutherland, team founder, said: “Here @CoClassicPro watching an all diabetic team race, and seeing all their blood glucose data on one chart. BIG Thx to @Microsoft Hack Team.”

Take a look at the overview of the race and then let me know what you think.

Dave Joffe

Editor-in-chief

Fresh off the Larry H. Miller Tour of Utah and with little time to recover, Team Novo Nordisk tackled the high-altitude Colorado Classic. Team Novo Nordisk’s squad included three neo-pros (new professionals), one stagiaire (basically an intern looking for a contract) and two veteran riders, so a very young and fairly inexperienced squad.

In the conclusion of this Exclusive Interview, Dr. Karl Nadolsky shares his treatment philosophy for lowering a patient’s A1C down without being too aggressive. Dr. Nadolsky talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas.

In this week’s Homerun Slides, the conclusion of Dr. Stanley Schwartz’s presentation on the beta-cell classification of diabetes and delaying the need for insulin.

It was a challenge to develop a computer model that could account for plasma dynamics in a compact but accurate package. The model was the simplest representation we could devise, which was based upon known physiology, and which could accurately describe moment-by-moment plasma dynamics. The model continues to thrive in that it continues to be the basis for a large number of clinical investigations (∼50 per year) as well as a robust literature related to its mathematical and computer characteristics

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.

Antioxidants and other polyphenols present in coffee confer healthy benefits to the body, which may include lowering insulin resistance, inflammation and biomarkers of liver function.

Combination ANRI sacubitril/valsartan (EntrestoR) showed significant reduction in risk for cardiovascular death and hospitalization for worsening heart failure.